- Categories:Industry form
- Author:
- Origin:
- Time of issue:2019-03-11
- Views:0
(Summary description)On September 7-9, 2018, the Cardiovascular Branch of the Chinese Medical Association held the National Cardiovascular Annual Conference and the 12th Qianjiang International Cardiovascular Conference (CSC&QICC2018) at Hangzhou International Expo Center, Zhejiang Province. This conference is a test of the results of cardiovascular disease prevention and scientific research in my country. It is the most authoritative and representative public academic exchange platform. More than 7,000 colleagues from the cardiovascular sciences at home and abroad gathered together to carry out colorful academic exchanges. Activity. At the opening ceremony of the conference, academician Ge Junbo, the chairperson of the conference, gave the opening theme report of the conference, and grandly introduced the milestones in the development of Chinese medical research.
(Summary description)On September 7-9, 2018, the Cardiovascular Branch of the Chinese Medical Association held the National Cardiovascular Annual Conference and the 12th Qianjiang International Cardiovascular Conference (CSC&QICC2018) at Hangzhou International Expo Center, Zhejiang Province. This conference is a test of the results of cardiovascular disease prevention and scientific research in my country. It is the most authoritative and representative public academic exchange platform. More than 7,000 colleagues from the cardiovascular sciences at home and abroad gathered together to carry out colorful academic exchanges. Activity. At the opening ceremony of the conference, academician Ge Junbo, the chairperson of the conference, gave the opening theme report of the conference, and grandly introduced the milestones in the development of Chinese medical research.
- Categories:Industry form
- Author:
- Origin:
- Time of issue:2019-03-11
- Views:0
On September 7-9, 2018, the Cardiovascular Branch of the Chinese Medical Association held the National Cardiovascular Annual Conference and the 12th Qianjiang International Cardiovascular Conference (CSC&QICC 2018) at Hangzhou International Expo Center, Zhejiang Province. This conference is a test of the results of cardiovascular disease prevention and scientific research in my country. It is the most authoritative and representative public academic exchange platform. More than 7,000 colleagues from the cardiovascular sciences at home and abroad gathered together to carry out colorful academic exchanges. Activity.
At the opening ceremony of the conference, the chairperson Academician Ge Junbo made the opening theme report of the conference, and grandly introduced the milestones in the development of Chinese medical research, CSPPT and precision medicine research on H-type hypertension, and emphasized the prevention and control of H-type hypertension in China’s cardiovascular field. It is important to highlight the important impact of CSPPT in the field of international cardiovascular prevention and control. It is an important achievement in China's cardiovascular field and an important contribution made by Chinese scholars to the international cardiovascular field. Professor Huo Yong, former cardiovascular director of the Chinese Medical Association’s Cardiovascular Branch, gave a keynote report on "H-type hypertension: a research paradigm in precision medicine for complex diseases", introducing the Chinese medical community in the field of H-type hypertension with Chinese characteristics Practice and exploration made clinically. Professor Li Jianping from Peking University First Hospital gave a conference report on "MTHFR genotype-based hyperhomocysteinemia control".
On the afternoon of September 7th, the first health economics forum in the cardiovascular field-Hypertension Health Economics Forum was hosted by Professor Lu Xinzheng, Secretary-General of the Hypertension Group, and Professor Jiang Jie, Director of the Institute of Health Economics of Jinan University The curtain began, the "Hangzhou Voice" of H-type hypertension officially opened its voice!
At this forum, Academician Ge Junbo, Professor Liu Guoen, Professor Zhou Maigeng, Professor Zhang Zugui, Professor Huo Yong, Professor David Cohen, Professor Alejandrn Arrieta, Professor Zhang Tiantian will conduct research on the health economics of hypertension in the cardiovascular field. A comprehensive explanation, and at the end of the forum, under the leadership of Professor Huo Yong, the National "Thirteenth Five-Year Plan" H-type Hypertension First Stroke Molecular Classification and Precision Medicine Research Center was awarded.
